Lunch with company reduces cognitive control, may increase social harmony

Context of working lunch influences post-meal cognition, emotion

2013-08-01

(Press-News.org) Lunch at a restaurant with friends reduces cognitive control more than lunch eaten alone at a desk does, according to research published July 31 in the open access journal PLOS ONE by Werner Sommer from the Humboldt University at Berlin, Germany, and colleagues from other institutions.

Participants in the study either ate a solitary meal alone at their desk in a restricted amount of time, or took a short walk to a restaurant for an hour-long lunch with a friend. All meals were identical in the kind and amounts of food consumed. After the meal, people who had a restaurant lunch were calmer and less wakeful than those who ate at their desks. They also fared more poorly on performance tests of cognitive control, and neurophysiological measurements indicated decreased cognitive control of performance and error monitoring processes. Since the meals differed in many ways including the presence of a friend, environment and lack of time restrictions, the authors explain "It is impossible to specify at this point, which of the variables above are crucial for the effects observed in our study."

They add, "Reduced cognitive control is a disadvantage when close self-monitoring of performance and detailed attention to errors is required, such as in numerical processing. In other situations, an attenuation of cognitive control may be advantageous, such as when social harmony or creativity is desired."

### Citation: Sommer W, Stürmer B, Shmuilovich O, Martin-Loeches M, Schacht A (2013) How about Lunch? Consequences of the Meal Context on Cognition and Emotion. PLOS ONE 8(7): e70314. doi:10.1371/journal.pone.0070314

Financial Disclosure: This research was supported by the Wolfgang-Köhler-Zentrum zur Erforschung von Konflikten in Intelligenten Systemen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interest Statement: The authors have declared that no competing interests exist.

PLEASE LINK TO THE SCIENTIFIC ARTICLE IN ONLINE VERSIONS OF YOUR REPORT (URL goes live after the embargo ends): http://dx.plos.org/10.1371/journal.pone.0070314

Disclaimer: This press release refers to upcoming articles in PLOS ONE. The releases have been provided by the article authors and/or journal staff. Any opinions expressed in these are the personal views of the contributors, and do not necessarily represent the views or policies of PLOS. PLOS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.

About PLOS ONE: PLOS ONE is the first journal of primary research from all areas of science to employ a combination of peer review and post-publication rating and commenting, to maximize the impact of every report it publishes. PLOS ONE is published by the Public Library of Science (PLOS), the open-access publisher whose goal is to make the world's scientific and medical literature a public resource.

All works published in PLOS ONE are Open Access. Everything is immediately available—to read, download, redistribute, include in databases and otherwise use—without cost to anyone, anywhere, subject only to the condition that the original authors and source are properly attributed. For more information about PLOS ONE relevant to journalists, bloggers and press officers, including details of our press release process and our embargo policy, see the everyONE blog at http://everyone.plos.org/media.

ELSE PRESS RELEASES FROM THIS DATE:

Placebo effects of different therapies not identical

2013-08-01

Not all placebos are equal, and patients who respond to one placebo don't always respond to others, according to research published July 31 in the open access journal PLOS ONE by Jian Kong from Massachusetts General Hospital, Harvard Medical School and colleagues from other institutions. The researchers tested the analgesic effects of genuine acupuncture, sham acupuncture and a placebo pill on healthy participants' pain sensitivity. Participants were not told what treatment they were receiving, but were informed that the pill was Tylenol, a well-known painkiller and different ...

New signal stabilizes atherosclerotic plaques

2013-08-01

Atherosclerosis is an inflammatory disease with accumulation of cholesterol in the vessel walls. The atherosclerotic plaque is built up throughout life and when it ruptures it leads to heart attack or stroke. T cells are important immune cells able to direct the immune response; they are present in the plaques at all stages and signal to other cells through contact or secretion of cytokines, a type of hormone-like signal molecules. In the present study the researchers have identified a cytokine produced by T cells that can stabilize atherosclerotic plaques and protect them ...

Digest this: Cure for cancer may live in our intestines

2013-08-01

ANN ARBOR—Treating a cancerous tumor is like watering a houseplant with a fire hose—too much water kills the plant, just as too much chemotherapy and radiation kills the patient before it kills the tumor. However, if the gastrointestinal tract remains healthy and functioning, the chances of survival increase exponentially, said Jian-Guo Geng, associate professor at the University of Michigan School of Dentistry. Recently, Geng's lab discovered a biological mechanism that preserves the gastrointestinal tracts in mice who were delivered lethal doses of chemotherapy. ...

Bird brains predate birds themselves

2013-08-01

VIDEO: This video shows the three-dimensional scan of an albatross (Phoebastria immutabilis) skull and brain endocast (shown in blue) taken with high-resolution X-ray computed tomography. The specimen is one of more... Click here for more information. New research provides evidence that dinosaurs evolved the brainpower necessary for flight well before they actually took to the air as birds. Based on high-resolution X-ray computed tomographic (CT) scans, the study, published ...

'Highway from hell' fueled Costa Rican volcano

2013-08-01

If some volcanoes operate on geologic timescales, Costa Rica's Irazú had something of a short fuse. In a new study in the journal Nature, scientists suggest that the 1960s eruption of Costa Rica's largest stratovolcano was triggered by magma rising from the mantle over a few short months, rather than thousands of years or more, as many scientists have thought. The study is the latest to suggest that deep, hot magma can set off an eruption fairly quickly, potentially providing an extra tool for detecting an oncoming volcanic disaster. "If we had had seismic instruments ...

Wonders of nature inspire exotic man-made materials

2013-08-01

In this month's edition of Physics World, a group of physicists describe how unique structures in the natural world are inspiring scientists to develop new types of materials with unprecedented properties. From adhesive tape inspired by the toes of geckoes to a potential flaw-resistant coating of aeroplanes inspired by mother of pearl, the attractiveness centres on one concept -- hierarchical design. When materials have a hierarchical design, the overall structure is made up of much smaller levels, or generations, of structures that when put together exhibit extraordinary ...

Internet-based training could help in the fight against antibiotic resistance

2013-08-01

Antibiotic prescribing rates for acute respiratory tract infections could be significantly lowered using internet-based training for clinicians, new research has shown. In a study, led by the University of Southampton and published in The Lancet today (Wednesday 31 July), an internet-based training programme has shown to reduce antibiotics prescribing rates by as much as 62 per cent. Paul Little, Professor of Primary Care Research at the University of Southampton, comments: "The high volume of prescribing antibiotics in primary care is a major driver of antibiotic resistance, ...

Clean water and soap may help improve growth in young children

2013-08-01

Improving water quality and hygiene practices may improve the growth of children, according to a new report. The Cochrane review – authored by the London School of Hygiene & Tropical Medicine and WaterAid – found evidence of small but significant improvements in growth of children under the age of five who have access to clean water and soap. Researchers identified 14 studies conducted in low and middle income countries (Bangladesh, Ethiopia, Nigeria, Chile, Guatemala, Pakistan, Nepal, South Africa, Kenya and Cambodia) that provided data on the effect of water, sanitation ...

Cleveland Clinic study finds lowest risk treatment for severe carotid and coronary disease

2013-08-01

JULY 31, 2013, Cleveland: Of the three most common treatment approaches for patients with severe carotid and coronary artery disease, patients who underwent stenting of the carotid artery followed by open heart surgery had the best outcomes, according to a retrospective study from Cleveland Clinic published online today in the Journal of the American College of Cardiology. The study compared carotid stenting followed by open heart surgery to both staged and combined carotid endarterectomy and open heart surgery. For patients with a severe blockage in the carotid artery ...

The flexible tail of the prion protein poisons brain cells

2013-08-01

VIDEO: Professor Adriano Aguzzi explains how the flexible tail of the prion protein poisons brain cells. Click here for more information. Prion proteins are the infectious pathogens that cause Mad Cow Disease and Creutzfeldt-Jakob disease. They occur when a normal prion protein becomes deformed and clumped. The naturally occurring prion protein is harmless and can be found in most organisms. In humans, it is found in our brain cell membrane. By contrast, the abnormally deformed ...

LAST 30 PRESS RELEASES:

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC